Skip to main content
SpringerLink
Log in

Combinations of Taxanes and Ionizing Radiation

  • Chapter
Multimodal Concepts for Integration of Cytotoxic Drugs

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 597 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bhalla K, Ilerado AM, Tourkina E et al (1993) Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563–568

    PubMed  CAS  Google Scholar 

  • Bissery MC, Vrignaud P, Lavelle F (1995) Preclinical profile of docetaxel (Taxotere): efficacy as a single agent and in combination. Semin Oncol 22(Suppl 13):3–16

    CAS  Google Scholar 

  • Blagosklonny MV, Schulte T, Nguyen P et al (1996) Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf-1 signal transduction pathway. Cancer Res 56:1851–1854

    PubMed  CAS  Google Scholar 

  • Bogden D, Ding AH (1992) Taxol, a microtubule stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J Leukoc Biol 52:119–121

    Google Scholar 

  • Brizel DM, Albers ME, Fisher SR et al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798–804

    Article  PubMed  CAS  Google Scholar 

  • Burkhart CA, Berman JW, Swindell CS et al (1994). Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-alpha gene expression and cytotoxicity. Cancer Res 54:5779–5782

    PubMed  CAS  Google Scholar 

  • Chen Y, Okunieff P (2004) Radiation and third-generation chemotherapy. Hematol Oncol Clin N Am 18:55–80

    Article  Google Scholar 

  • Choy H (2000) Taxanes in combined modality therapy for solid tumors. Crit Rev Oncol Hematol 37:237–247

    Google Scholar 

  • Choy H, Rodriguez FF, Koester S et al (1993) Investigation of taxol as a potential radiation sensitizer. Cancer 71:3774–3778

    Article  PubMed  CAS  Google Scholar 

  • Choy H, Akerley W, Safran H et al (1994) Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J Clin Oncol 12:2682–2686

    PubMed  CAS  Google Scholar 

  • Debernardis D, Graniela-Sire E, De Feudis P et al (1997) p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res 57:870–874

    PubMed  CAS  Google Scholar 

  • Figgitt DP, Wiseman LR (2000) Docetaxel an update of its use in advance breast cancer. Drugs 59:621–651

    Article  PubMed  CAS  Google Scholar 

  • Furuse K, Fukuoka M, Kawahara M et al (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17: 2692–2699

    PubMed  CAS  Google Scholar 

  • Gangemi RMR, Tiso M, Marchetti C et al (1995) Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol 36:385–392

    PubMed  CAS  Google Scholar 

  • Geard CR, Jones JM (1994) Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 29:565–569

    PubMed  CAS  Google Scholar 

  • Gigorov J, Lotz JP (2004) Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 9:3–8

    Article  Google Scholar 

  • Gorski DH, Beckett MA, Jaskowiak NT et al (1999) Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59:3374–3378

    PubMed  CAS  Google Scholar 

  • Graniela-Sire EA, Vikhanskaya F, Broggini M (1995) Sensitivity and cellular response to different anticancer agents of a human ovarian cancer cell line expressing wild-type, mutated or no p53. Ann Oncol 6:589–593

    PubMed  CAS  Google Scholar 

  • Griffon-Etienne G, Merlin JL, Marchal C (1996) In vitro evaluation of taxol combined with radiation in human squamous cell carcinoma spheroids. Cancer Lett 109:23–32

    Article  PubMed  CAS  Google Scholar 

  • Griffon-Etienne G, Boucher Y, Brekken C et al (1999) Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res 59:3776–3782

    PubMed  CAS  Google Scholar 

  • Grunberg E, Eckert K, Maurer HR (1998) Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. Int J Oncol 12:957–963

    PubMed  CAS  Google Scholar 

  • Gueritte-Voegelein F, Guenard D, Lavelle F et al (1991) Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 34:992–998

    Article  PubMed  CAS  Google Scholar 

  • Gupta N, Hu LJ, Deen DF (1997) Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. Int J Radiat Oncol Biol Phys 37:885–895

    Article  PubMed  CAS  Google Scholar 

  • Haimovitz-Friedman A, Vlodavsky I, Chaudhur A et al (1991) Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 51:2552–2558

    PubMed  CAS  Google Scholar 

  • Haldar S, Chintapalli J, Croce CM (1996) Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56:1253–1255

    PubMed  CAS  Google Scholar 

  • Haldar, S, Basu A, Croce CM (1997) Bcl-2 is the guardian of microtubule integrity. Cancer Res 57:229–233

    PubMed  CAS  Google Scholar 

  • Hanauske AR, Degen D, Hilsenbeck SG et al (1992) Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anticancer Drugs 3:121–124

    Article  PubMed  CAS  Google Scholar 

  • Hennequin N, Giocanti N, Favaudon V (1995) S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells. Br J Cancer 71:1194–1198

    PubMed  CAS  Google Scholar 

  • Hennequin C, Giocanti N, Favaudon V (1996) Interaction of ionizing radiation with paclitaxel (taxol) and docetaxel (taxotere) in HeLa and SQ20B cells. Cancer Res 56:1842–1850

    PubMed  CAS  Google Scholar 

  • Herskovic A, Martz K, Al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598

    Article  PubMed  CAS  Google Scholar 

  • Horwitz SB (2004) Personal recollections of the early development of taxol. J Nat Prod 67:136–138

    Article  PubMed  CAS  Google Scholar 

  • Ingram ML, Redpath JL (1997) Subadditive interaction of radiation and taxol in vitro. Int J Radiat Oncol Biol Phys 37:1139–1144

    Article  PubMed  CAS  Google Scholar 

  • Jaakkola M, Rantanen V, Grenman S et al (1996) In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines. Cancer 77:1940–1946

    Article  PubMed  CAS  Google Scholar 

  • Joschko MA, Webster LK, Groves J et al (1994) Taxol enhances radiation effect in a hypopharyngeal xenograft. Forty-Second Annual Meeting of the Radiation Research Society Book of Abstracts p. 206, (Abstr no. P24–400)

    Google Scholar 

  • Kastan MB, Canman CE, Leonard CJ (1995) P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14:3–15

    Article  PubMed  CAS  Google Scholar 

  • Kelland LR, Abel G (1992) Comparative in vitro cytotoxicity of taxol and taxotere against cisplatin-sensitive and-resistant human ovarian cancer cell lines. Cancer Chemother Pharmacol 30:444–450

    Article  PubMed  CAS  Google Scholar 

  • Lavelle F, Bissery MC, Combeau C et al (1995) Preclinical evaluation of docetaxel (taxotere). Semin Oncol 22(Suppl 4):3–16

    CAS  Google Scholar 

  • Lee L-F, Li G, Templeton DJ et al (1998) Paclitaxel (taxol)-induced gene expression and cell death are both mediated by activation of c-Jun NH2-terminal kinase (JNK/SAPK). J. Biol Chem 273:28253–28260

    Article  PubMed  CAS  Google Scholar 

  • Leonard CE, Chan DC, Chou TC et al (1996) Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res 56:5198–5204

    PubMed  CAS  Google Scholar 

  • Li C, Price JE, Milas L et al (1999) Antitumor activity of Poly (L-glutamic acid)-Paclitaxel on syngeneic and xenografted tumors. Clin Cancer Res 5:891–897

    PubMed  CAS  Google Scholar 

  • Li C, Ke S, Wu QP et al (2000a) Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate. Int J Radiat Oncol Biol Phys 48:1119–1126

    Article  PubMed  CAS  Google Scholar 

  • Li C, Ke S, Wu QP et al (2000b) Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. Clin Cancer Res 6:2829–2834

    PubMed  CAS  Google Scholar 

  • Liebmann J, Cook JA, Fisher J et al (1994a) Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol). Int J Radiat Oncol Biol Phys 29:559–564

    PubMed  CAS  Google Scholar 

  • Liebmann J, Cook JA, Fisher J et al (1994b) In vitro studies of taxol as a potential radiation sensitizer. J Natl Cancer Inst 86:441–446

    PubMed  CAS  Google Scholar 

  • Liebmann J, Herscher L, Fisher J et al (1996) Antagonism of paclitaxel cytotoxicity by X-rays: implications for the sequence of combined modality therapy. Int J Oncol 8:991–996

    CAS  Google Scholar 

  • Lokeshwar BL, Farrell SM, Block NL (1995) Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy. Anticancer Res 15:93–98

    PubMed  CAS  Google Scholar 

  • Lowe SW, Ruley HE, Jacks T et al (1993) p-53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957–967

    Article  PubMed  CAS  Google Scholar 

  • Mangatal L, Adeline MT, Guenard D et al (1989) Application of the vicinal hydroxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogs. Tetrahedron 45:4177–4190

    Article  CAS  Google Scholar 

  • Manthey CL, Perera PY, Salkowski CA et al (1994) Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol 152:825–831

    PubMed  CAS  Google Scholar 

  • Mason KA, Milas L, Peters LJ (1995) Effect of paclitaxel (Taxol) alone and in combination with radiation on the gastrointestinal mucosa. Int J Radiat Oncol Biol Phys 32:1381–1389

    Article  PubMed  CAS  Google Scholar 

  • Mason KA, Hunter NR, Milas M et al (1997) Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res 3:2431–2438

    PubMed  CAS  Google Scholar 

  • Mason KA, Kishi K, Hunter N et al (1999) Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Clin Cancer Res 54:4191–4198

    Google Scholar 

  • Mason K, Staab A, Hunter N et al (2001a) Enhancement of tumor radioresponse by docetaxel: involvement of immune system. Int J Oncol 18:599–606

    PubMed  CAS  Google Scholar 

  • Mason KA, Komaki R, Cox JD et al (2001b) Biology-based combined-modality radiotherapy: workshop report. Int J Radiat Oncol Biol Phys 50:1079–1089

    Article  PubMed  CAS  Google Scholar 

  • Mason KA, Wiedenmann N, Valdecanas D et al (in press) ABI-007, nanoparticle albumin-bound paclitaxel, enhances tumor radioresponse. Proc American Association of Cancer Research meeting, Abstract no. 06-AB-3086

    Google Scholar 

  • Milas L, Hunter NR, Mason KA et al (1994) Enhancement of tumor radioresponse of a murine mammary carcinoma by taxol. Cancer Res 54:3506–3510

    PubMed  CAS  Google Scholar 

  • Milas L, Hunter NR, Kurdoglu B et al (1995a) Kinetics of mitotic arrest and apoptosis in murine mammary ovarian tumors treated with taxol. Cancer Chemother Pharmacol 35:297–303

    PubMed  CAS  Google Scholar 

  • Milas L, Hunter NR, Mason KA et al (1995b) Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 55:3564–3568

    PubMed  CAS  Google Scholar 

  • Milas L, Saito Y, Hunter NR et al (1996) Therapeutic potential of paclitaxel radiation treatment of a murine ovarian carcinoma. Radiother Oncol 40:163–170

    Article  PubMed  CAS  Google Scholar 

  • Milas L, Milas M, Mason KA (1999) Combination of taxanes with radiation: preclinical studies. Semin Radiat Oncol 9:12–26

    PubMed  CAS  Google Scholar 

  • Milas L, Mason KA, Hunter N et al (2003a) Poly (L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability. Int J Radiat Oncol Biol Phys 55:707–712

    Article  PubMed  CAS  Google Scholar 

  • Milas L, Mason KA, Liao Z et al (2003b) Chemoradiotherapy: emerging treatment improvement strategies. Head Neck 25:152–167

    Article  PubMed  Google Scholar 

  • Milross CG, Mason KA, Hunter NR et al (1996) Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 88:1308–1314

    PubMed  CAS  Google Scholar 

  • Milross CG, Mason KA, Hunter NR et al (1997) Enhanced radioresponse of paclitaxel-sensitive and-resistant tumors in vivo. Eur J Cancer 33:1299–1308

    Article  PubMed  CAS  Google Scholar 

  • Minarik L, Hall EJ (1994) Taxol in combination with acute and low dose rate irradiation. Radiother Oncol 32:124–128

    Article  PubMed  CAS  Google Scholar 

  • Morris M, Eifel PJ, Lu J et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143

    Article  PubMed  CAS  Google Scholar 

  • Morse DL, Gray H, Payne CM et al (2005) Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther 4:1495–1504

    Article  PubMed  CAS  Google Scholar 

  • Piccart MJ, Gore M, Huinink WTB et al (1995) Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer. J Natl Cancer Inst 87:676–681

    PubMed  CAS  Google Scholar 

  • Ringel I, Horwitz SB (1991) Studies with RP 56976 (Taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83:288–291

    PubMed  CAS  Google Scholar 

  • Rodriguez M, Sevin BU, Perras J et al (1995) Paclitaxel: a radiation sensitizer of human cervical cancer cells. Gynecol Oncol 57:165–169

    Article  PubMed  CAS  Google Scholar 

  • Rosell R, Gonzalez-Larriba JL, Alberola V et al (1995) Single-agent paclitaxel by 3-hour infusion in the treatment of nonsmall cell lung cancer: links between p53 and K-ras gene status and chemosensitivity. Semin Oncol 22:12–18

    PubMed  CAS  Google Scholar 

  • Rowinsky EK, Donehower RC (1995) Paclitaxel (Taxol). N Engl J Med 332:1004–1014

    Article  PubMed  CAS  Google Scholar 

  • Schiff PB, Horwitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561–1565

    Article  PubMed  CAS  Google Scholar 

  • Schiff PB, Fant S, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665–667

    Article  PubMed  CAS  Google Scholar 

  • Schimming R, Mason KA, Hunter N et al (1999a) Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel. Cancer Chemother Pharmacol 43:165–172

    Article  PubMed  CAS  Google Scholar 

  • Schimming R, Hunter NR, Mason KA et al (1999b) Apoptosis and inhibition of neoangiogenesis as mechanisms of antitumor action by docetaxel (Taxotere). Mund Kiefer Gesichts Chir 3:210–212

    Article  CAS  Google Scholar 

  • Shim J, Lee H, Park J et al (1996) A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381:804–806

    Article  PubMed  CAS  Google Scholar 

  • Sinclair WK, Morton RA (1966) X-ray sensitivity during the cell generation cycle of cultured Chinese hamster ovary cells. Radiat Res 29:450–474

    PubMed  CAS  Google Scholar 

  • Singer JW, Shaffer S, Baker B et al (2005) Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane. Anti Cancer Drugs 16:243–254

    Article  PubMed  CAS  Google Scholar 

  • Sparreboom A, Scripture CD, Trieu V, et al (2005) Comparative preclinical and clinical pharmacokinetics of a cremophorfree, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in cremophor (Taxol). Clin Cancer Res 11:4136–4143

    Article  PubMed  CAS  Google Scholar 

  • Steren A, Sevin BU, Perras J et al (1993) Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol 48:252–258

    Article  PubMed  CAS  Google Scholar 

  • Stromberg JS, Lee YJ, Armour EP et al (1995) Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines. Cancer 75:2262–2268

    Article  PubMed  CAS  Google Scholar 

  • Sweeney CJ, Miller KD, Sissons SE et al (2001) The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors. Cancer Res 61:3369–3372

    PubMed  CAS  Google Scholar 

  • Terasima T, Tolmach LJ (1963) Variations in several responses of HeLa cells to X-irradiation during the division cycle. Biophys J 3:11–33

    Article  PubMed  CAS  Google Scholar 

  • Tishler RB, Geard CR, Hall EJ, Schiff PB (1992a) Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52:3495–3497

    PubMed  CAS  Google Scholar 

  • Tishler RB, Schiff PB, Geard CR et al (1992b) Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys 22:613–617

    PubMed  CAS  Google Scholar 

  • Tishler RB, Lampus DM, Park S et al (1995) Microtubuleactive drugs taxol, vinblastine, and nocodazole increase the level of transcriptionally active p53. Cancer Res 55:6021–6025

    PubMed  CAS  Google Scholar 

  • Torres K, Horwitz SB (1998) Mechanisms of taxol-induced cell death are concentration dependent. Cancer Res 58:3620–3626

    PubMed  CAS  Google Scholar 

  • Van Rijn J, Van Den Berg J, Meijer OW (1995) Proliferation and clonal survival of human lung cancer cells treated with fractionated irradiation in combination with paclitaxel. Int J Radiat Oncol Biol Phys 33:635–639

    Article  PubMed  Google Scholar 

  • Wahl AF, Donaldson KL, Fairchild C et al (1996) Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nature Med 2:72–79

    Article  PubMed  CAS  Google Scholar 

  • Wang T-H, Popp DM, Wang H-S et al (1999) Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and-independent pathways in ovarian cancer cells. J Biol Chem 274:8208–8216

    Article  PubMed  CAS  Google Scholar 

  • Wani MC, Taylor HL, Wall ME et al (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325–2327

    Article  PubMed  CAS  Google Scholar 

  • Withers HR, Elkind MM (1970) Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol 17:261–267

    CAS  Google Scholar 

  • Woods CM, Zhu J, Mcqueney PA et al (1995) Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med 1:506–526

    PubMed  CAS  Google Scholar 

  • Xia Z, Dickens M, Raingeaud J et al (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Scinece 270:1326–1331

    CAS  Google Scholar 

  • Zanelli GD, Quaia M, Robieux I et al (1997) Paclitaxel as a radiosenitizer: a proposed schedule of administration based on in vitro data and pharmacokinetic calculations. Eur J Cancer 33:486–492

    Article  PubMed  CAS  Google Scholar 

  • Zhao J, Kim JE, Reed E et al (2005) Molecular mechanism of antitumor activity of taxanes in lung cancer (Review). Int J Oncol 27:247–256

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental Radiation Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030-4009, USA

    Luka Milas MD, PhD (Professor), Kathryn A. Mason MS & Zhongxing Liao MD (Associate Professor)

  2. Departments of Experimental Radiation Oncology and Radiation Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030-4009, USA

    Kian K. Ang MD, PhD (Professor)

Authors
  1. Luka Milas MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathryn A. Mason MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhongxing Liao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kian K. Ang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford School of Medicine, 269 Campus Drive Center for Clinical Science and Research, Rm 1255, Stanford, CA, 94305-5152, USA

    J. Martin Brown PhD

  2. Department of Human Oncology, University of Wisconsin Hospital Medical School, 600 Highland Ave., K4 312-3684, Madison, WI, 53792, USA

    Minesh P. Mehta MD

  3. Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Strasse 22, 81675, München, Germany

    Carsten Nieder MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Milas, L., Mason, K.A., Liao, Z., Ang, K.K. (2006). Combinations of Taxanes and Ionizing Radiation. In: Brown, J.M., Mehta, M.P., Nieder, C. (eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35662-2_3

Download citation

  • DOI: https://doi.org/10.1007/3-540-35662-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25655-7

  • Online ISBN: 978-3-540-35662-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation